Back

Adverse glycaemic measures in cardiac patients: HbA1c fails to provide the full picture.

30 August 2021 (09:03 - 09:13)
Organised by:
Congress Presentation Part of: Modern Glycaemic Management to reduce CV risk in Diabetes Cardiovascular Disease in Specific Populations Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Ramzi Ajjan

University of Leeds, Leeds (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
Introduction.
Professor N. Marx (Aachen, DE)
Video
Presentation thumbnail
Is continuous glucose monitoring the solution?
Associate Professor G. Lanza (Rome, IT)
Slides Video
Presentation thumbnail
Live Questions & Answers.
Video

Access the full session

Session thumbnail
Modern Glycaemic Management to reduce CV risk in Diabetes
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

30 August 2021 09:03 CET
You may be interested in
thumbnail
Congress Presentation
Hba1c variability is associated with adverse outcomes in heart failure patients with and without diabetes
21 May 2023
thumbnail
Congress Session
Adjunct pharmacology in PCI: beyond antiplatelet therapy, the next chapter
30 August 2024
thumbnail
Congress Presentation
Non-invasive continuous glucose monitoring in patients without diabetes: use in cardiovascular prevention - a systematic review
3 April 2025
thumbnail
Congress Presentation
Impact of high-intensity statin therapy on glycemic control post-acute coronary syndrome using real-world data
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources